Pernix Provides Business Update
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (the "Company"), a specialty pharmaceutical company, today updated its full-year 2015 net sales guidance and business outlook.
The Company anticipates net sales for the three-months ended March 31, 2015, will be between $32 million and $35 million, compared with $19 million for the same period in 2014.
Help employers find you! Check out all the jobs and post your resume.
The Company anticipates net sales for the three-months ended March 31, 2015, will be between $32 million and $35 million, compared with $19 million for the same period in 2014.
Help employers find you! Check out all the jobs and post your resume.